NCT00030784View on ClinicalTrials.gov

Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

March 31, 2005

Conditions

Sarcoma

Interventions

DRUG

ifosfamide

DRUG

pegylated liposomal doxorubicin hydrochloride

Trial Locations (2)

DK-8000

Aarhus University Hospital - Aarhus Sygehus - Norrebrogade, Aarhus

D-13122

Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch, Berlin

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00030784 - Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter